Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Pharma
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
Taking Zepbound with Taltz could help patients with both obesity and psoriatic arthritis more than Taltz on its own, according to new Eli Lilly data.
Fraiser Kansteiner
Jan 8, 2026 2:00pm
Regulatory tracker: Rubraca scores full prostate cancer approval
Dec 18, 2025 2:45pm
Alvotech plant issues trigger another FDA biosimilar rejection
Nov 4, 2025 7:40am
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
Nov 3, 2025 11:13am
Argenx lays out details on Vyvgart's seronegative gMG win
Oct 29, 2025 2:34pm
Roche pads case for Gazyva in immune-mediated kidney conditions
Oct 28, 2025 9:55am
